Companies Cryptocurrencies
Cassava Sciences Inc
Cassava Sciences Inc
Exchange: NasdaqCM
IPO Date: 14/07/2000
CEO: Mr. Remi Barbier
Biotechnology Healthcare đź”—
  • SAVA
  • 49.69
  • 1988330368
    market cap
  • -3.6800003
If you bought

shares of Cassava Sciences Inc (SAVA) on
You would have made
Old Price $12 Current Price $12

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. The company is headquartered in Austin, Texas and currently employs 9 full-time employees. The firm is focused on developing drug for the treatment of nervous system disorders. The firm is ocused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer’s. Its drug candidate, PTI-125, is a small molecule that targets an altered form of a scaffolding protein called filamin A (FLNA). The firm is also developing an experimental biomarker/diagnostic, PTI-125Dx. The company is developing PTI-125Dx to detect Alzheimer’s disease with a blood test.

Address: 7801 N Capital of Texas Hwy Ste 260 Austin TEXAS 78731

Stay updated.